Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$441M |
| 2 |
Broadcom
AVGO
|
+$328M |
| 3 |
Pfizer
PFE
|
+$292M |
| 4 |
Tesla
TSLA
|
+$252M |
| 5 |
IBM
IBM
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$295M |
| 2 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$138M |
| 3 |
General Mills
GIS
|
+$131M |
| 4 |
Chevron
CVX
|
+$116M |
| 5 |
PPG Industries
PPG
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Financials | 13.22% |
| 3 | Healthcare | 13.19% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Humacyte
HUMA
$176M
| $991K | ﹤0.01% |
303,724
-26,782
| -8% | -$103K |
|
|
EGIO
2802
DELISTED
Edgio, Inc. Common Stock
EGIO
| $985K | ﹤0.01% |
8,856
+55
| +0.6% | +$6.51K |
|
|
LBC
2803
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $984K | ﹤0.01% |
84,655
-7,229
| -8% | -$93K |
|
|
APPH
2804
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $983K | ﹤0.01% |
498,650
+46,443
| +10% | +$150K |
|
2805
Omeros
OMER
$857M
| $971K | ﹤0.01% |
308,239
+27,373
| +10% | +$127K |
|
2806
Vishay Precision Group
VPG
$1.22B
| $970K | ﹤0.01% |
32,775
+70
| +0.2% | +$2.23K |
|
|
CSTR
2807
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $966K | ﹤0.01% |
52,081
+2
| +0% | +$40 |
|
2808
Radiant Logistics
RLGT
$386M
| $964K | ﹤0.01% |
169,298
+38
| +0% | +$267 |
|
|
SMLR
2809
DELISTED
Semler Scientific
SMLR
| $959K | ﹤0.01% |
25,517
+4,333
| +20% | +$164K |
|
2810
Traeger
COOK
$178M
| $948K | ﹤0.01% |
6,722
+3,265
| +94% | +$551K |
|
2811
Citizens & Northern Corp
CZNC
$456M
| $945K | ﹤0.01% |
39,055
-50
| -0.1% | -$1.22K |
|
2812
Hingham Institution for Saving
HIFS
$627M
| $940K | ﹤0.01% |
3,742
-169
| -4% | -$49.4K |
|
|
EHAB
2813
DELISTED
Enhabit
EHAB
| $930K | ﹤0.01% |
+66,204
| New | +$1.07M |
|
2814
Five Star Bancorp
FSBC
$1.14B
| $922K | ﹤0.01% |
32,498
+2,752
| +9% | +$72.3K |
|
|
KALV
2815
DELISTED
KalVista Pharmaceuticals
KALV
| $916K | ﹤0.01% |
63,116
+217
| +0.3% | +$3.03K |
|
|
PSTX
2816
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $916K | ﹤0.01% |
259,291
+126,872
| +96% | +$420K |
|
2817
Vuzix
VUZI
$194M
| $910K | ﹤0.01% |
157,087
+85
| +0.1% | +$656 |
|
|
FRGE
2818
DELISTED
Forge Global Holdings
FRGE
| $908K | ﹤0.01% |
34,577
-15,127
| -30% | -$1.04M |
|
|
ALBO
2819
DELISTED
Albireo Pharma Inc
ALBO
| $907K | ﹤0.01% |
46,834
+515
| +1% | +$10.7K |
|
|
VTNR
2820
DELISTED
Vertex Energy, Inc
VTNR
| $905K | ﹤0.01% |
145,155
+5,569
| +4% | +$51K |
|
|
AUD
2821
DELISTED
Audacy, Inc.
AUD
| $901K | ﹤0.01% |
2,331,722
+1,223,555
| +110% | +$739K |
|
2822
NuScale Power
SMR
$2.91B
| $898K | ﹤0.01% |
76,822
+31,288
| +69% | +$411K |
|
|
ZY
2823
DELISTED
Zymergen Inc. Common Stock
ZY
| $891K | ﹤0.01% |
320,409
+256,265
| +400% | +$622K |
|
|
TCDA
2824
DELISTED
Tricida, Inc. Common Stock
TCDA
| $890K | ﹤0.01% |
84,917
-3,773
| -4% | -$41.3K |
|
2825
Bridgewater Bancshares
BWB
$571M
| $889K | ﹤0.01% |
53,924
-9
| -0% | -$154 |
|
Similar funds
Charles Schwab's Q3 2022 Portfolio in Review
As of Q3 2022, Charles Schwab held 3,614 positions worth $279B, down 2.9% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab deployed $8.77B of net new capital in Q3 2022, opening 79 new positions and adding to 2,461 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $295M trimmed.
- Charles Schwab's largest Q3 2022 buy was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
- Charles Schwab added most to Verizon in Q3 2022, an estimated $441M increase.
- Charles Schwab's biggest Q3 2022 reduction was iShares National Muni Bond ETF, cutting an estimated $295M.
- Charles Schwab fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $91.4M.
- Charles Schwab's ten largest holdings make up 17% of its $279B portfolio in Q3 2022.
- Charles Schwab opened 79 new positions and closed 105 in Q3 2022.
- Charles Schwab's portfolio value fell 2.9% quarter-over-quarter to $279B.
Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.